Real-world efficacy and safety of immune checkpoint blockades in advanced urothelial carcinoma with histologic variant subtypes: the pembroblad study
Abstract Background Histologic variants (HV) of urothelial carcinoma (UC-V) and non-urothelial carcinomas (NUC) of the bladder and urinary tract are aggressive malignancies with poor prognosis and limited response to platinum-based chemotherapy. Despite their biological particularities and distinct...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer
2026-05-01
|
| Reeks: | Cancer Immunology, Immunotherapy |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1007/s00262-026-04421-z |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
